Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Examining adjuvant radiation dose in head and neck squamous cell carcinoma.

Avkshtol V, Handorf EA, Ridge JA, Leachman BK, Liu JC, Bauman J, Galloway TJ.

Head Neck. 2019 Feb 9. doi: 10.1002/hed.25680. [Epub ahead of print]

PMID:
30737968
2.

NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.

Haddad RI, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Goldner W, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McIver B, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sippel R, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Johnson-Chilla A, Hoffmann KG, Gurski LA.

J Natl Compr Canc Netw. 2018 Dec;16(12):1429-1440. doi: 10.6004/jnccn.2018.0089.

PMID:
30545990
3.

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.

Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT.

Lancet. 2019 Jan 5;393(10166):40-50. doi: 10.1016/S0140-6736(18)32779-X. Epub 2018 Nov 15.

PMID:
30449625
4.

In Regard to Bossi et al.

Fakhry C, Nguyen-Tân PF, Lambert L, Rosenthal DI, Weber RS, Gillison ML, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):669-670. doi: 10.1016/j.ijrobp.2018.06.020. No abstract available.

PMID:
30238902
5.

AHNS Series: Do you know your guidelines? Optimizing outcomes in reoperative parathyroid surgery: Definitive multidisciplinary joint consensus guidelines of the American Head and Neck Society and the British Association of Endocrine and Thyroid Surgeons.

Stack BC Jr, Tolley NS, Bartel TB, Bilezikian JP, Bodenner D, Camacho P, Cox JPDT, Dralle H, Jackson JE, Morris JC 3rd, Orloff LA, Palazzo F, Ridge JA, Scott-Coombes D, Steward DL, Terris DJ, Thompson G, Randolph GW.

Head Neck. 2018 Aug;40(8):1617-1629. doi: 10.1002/hed.25023. Epub 2018 Aug 2.

PMID:
30070413
6.

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026.

PMID:
29752322
7.

Surgical management of the recurrent laryngeal nerve in thyroidectomy: American Head and Neck Society Consensus Statement.

Fundakowski CE, Hales NW, Agrawal N, Barczyński M, Camacho PM, Hartl DM, Kandil E, Liddy WE, McKenzie TJ, Morris JC, Ridge JA, Schneider R, Serpell J, Sinclair CF, Snyder SK, Terris DJ, Tuttle RM, Wu CW, Wong RJ, Zafereo M, Randolph GW.

Head Neck. 2018 Apr;40(4):663-675. doi: 10.1002/hed.24928. Epub 2018 Feb 20.

PMID:
29461666
8.

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.

Fakhry C, Zhang Q, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT, Gillison ML.

J Clin Oncol. 2017 Dec 20;35(36):4057-4065. doi: 10.1200/JCO.2016.72.0748. Epub 2017 Aug 4.

9.

Lymph-node-positive cutaneous nonmelanoma skin cancer: A poor-prognosis disease in need of treatment intensification.

Wang LS, Handorf EA, Ridge JA, Burtness BA, Lango MN, Mehra R, Liu JC, Galloway TJ.

Ear Nose Throat J. 2017 Jul;96(7):E12-E18.

PMID:
28719713
10.

Long-term toxicities in 10-year survivors of radiation treatment for head and neck cancer.

Dong Y, Ridge JA, Li T, Lango MN, Churilla TM, Bauman JR, Galloway TJ.

Oral Oncol. 2017 Aug;71:122-128. doi: 10.1016/j.oraloncology.2017.05.009. Epub 2017 Jun 23.

PMID:
28688679
11.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL Jr, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.

PMID:
28596256
12.

Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.

Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP.

CA Cancer J Clin. 2017 Mar;67(2):122-137. doi: 10.3322/caac.21389. Epub 2017 Jan 27.

13.

ACR appropriateness criteria® nasal cavity and paranasal sinus cancers.

Siddiqui F, Smith RV, Yom SS, Beitler JJ, Busse PM, Cooper JS, Hanna EY, Jones CU, Koyfman SA, Quon H, Ridge JA, Saba NF, Worden F, Yao M, Salama JK; Expert Panel on Radiation Oncology - Head and Neck Cancer.

Head Neck. 2017 Mar;39(3):407-418. doi: 10.1002/hed.24639. Epub 2016 Dec 29. Review.

14.

Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.

Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O'Sullivan B, Burtness BA, Butterfield LH, Carson WE, Disis ML, Fox BA, Gajewski TF, Gillison ML, Hodge JW, Le QT, Raben D, Strome SE, Lynn J, Malik S.

Cancer. 2017 Apr 1;123(7):1259-1271. doi: 10.1002/cncr.30449. Epub 2016 Dec 1.

15.

The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer.

Shaikh T, Handorf EA, Murphy CT, Mehra R, Ridge JA, Galloway TJ.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):967-975. doi: 10.1016/j.ijrobp.2016.08.046. Epub 2016 Sep 6.

16.

Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.

Beck TN, Smith CH, Flieder DB, Galloway TJ, Ridge JA, Golemis EA, Mehra R.

Head Neck. 2017 Mar;39(3):E34-E39. doi: 10.1002/hed.24604. Epub 2016 Nov 8. Review.

17.

Cervical metastasis in squamous cell carcinoma of the hard palate and maxillary alveolus.

Koshkareva Y, Liu JC, Lango M, Galloway T, Gaughan JP, Ridge JA.

Ear Nose Throat J. 2016 Oct-Nov;95(10-11):E6-E11.

PMID:
27792826
18.

EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer.

Beck TN, Georgopoulos R, Shagisultanova EI, Sarcu D, Handorf EA, Dubyk C, Lango MN, Ridge JA, Astsaturov I, Serebriiskii IG, Burtness BA, Mehra R, Golemis EA.

Mol Cancer Ther. 2016 Oct;15(10):2486-2497. Epub 2016 Aug 9.

19.

Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129.

Galloway TJ, Zhang QE, Nguyen-Tan PF, Rosenthal DI, Soulieres D, Fortin A, Silverman CL, Daly ME, Ridge JA, Hammond JA, Le QT.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):362-371. doi: 10.1016/j.ijrobp.2016.05.026. Epub 2016 May 28.

20.

ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.

Beitler JJ, Quon H, Jones CU, Salama JK, Busse PM, Cooper JS, Koyfman SA, Ridge JA, Saba NF, Siddiqui F, Smith RV, Worden F, Yao M, Yom SS; Expert Panel on Radiation Oncology - Head and Neck.

Head Neck. 2016 Sep;38(9):1299-309. doi: 10.1002/hed.24447. Epub 2016 Jun 22. Review.

21.

Early oral tongue cancer initially managed with surgery alone: Treatment of recurrence.

Liu JC, Sopka DS, Mehra R, Lango MN, Fundakowski C, Ridge JA, Galloway TJ.

World J Otorhinolaryngol Head Neck Surg. 2016 May 5;2(4):193-197. doi: 10.1016/j.wjorl.2016.03.001. eCollection 2016 Dec.

22.

ACR Appropriateness criteria® for nasopharyngeal carcinoma.

Saba NF, Salama JK, Beitler JJ, Busse PM, Cooper JS, Jones CU, Koyfman S, Quon H, Ridge JA, Siddiqui F, Worden F, Yao M, Yom SS; Expert Panel on Radiation Oncology-Head and Neck Cancer.

Head Neck. 2016 Jul;38(7):979-86. doi: 10.1002/hed.24423. Epub 2016 Apr 30. Review.

PMID:
27131050
23.

Reply to P. Blanchard et al.

Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Ridge JA.

J Clin Oncol. 2016 Jul 1;34(19):2318-9. doi: 10.1200/JCO.2016.67.2832. Epub 2016 Apr 25. No abstract available.

PMID:
27114603
24.

Papillary Thyroid Carcinoma Metastases Presenting as Ipsilateral Adrenal Mass and Renal Cyst.

Ginzburg S, Reddy M, Veloski C, Sigurdson E, Ridge JA, Azrilevich M, Kutikov A.

Urol Case Rep. 2015 Sep 16;3(6):221-2. doi: 10.1016/j.eucr.2015.08.007. eCollection 2015 Nov.

25.

ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.

Koyfman SA, Cooper JS, Beitler JJ, Busse PM, Jones CU, McDonald MW, Quon H, Ridge JA, Saba NF, Salama JK, Siddiqui F, Smith RV, Worden F, Yao M, Yom SS.

Head Neck. 2016 Feb;38(2):175-82. doi: 10.1002/hed.24171.

26.

Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.

Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, Flieder DB, Ridge JA.

J Clin Oncol. 2016 Jan 10;34(2):169-78. doi: 10.1200/JCO.2015.61.5906. Epub 2015 Nov 30.

27.

Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer.

Murphy CT, Devarajan K, Wang LS, Mehra R, Ridge JA, Fundakowski C, Galloway TJ.

Oral Oncol. 2015 Nov;51(11):1034-1040. doi: 10.1016/j.oraloncology.2015.09.001. Epub 2015 Oct 5.

PMID:
26410020
28.

Anaplastic Thyroid Carcinoma, Version 2.2015.

Haddad RI, Lydiatt WM, Ball DW, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McCaffrey JC, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Hoffmann KG, Hughes M.

J Natl Compr Canc Netw. 2015 Sep;13(9):1140-50.

29.

Management of Squamous Cancer Metastatic to Cervical Nodes With an Unknown Primary Site.

Galloway TJ, Ridge JA.

J Clin Oncol. 2015 Oct 10;33(29):3328-37. doi: 10.1200/JCO.2015.61.0063. Epub 2015 Sep 8. Review.

PMID:
26351351
30.

Impact of baseline patient-reported dysphagia on acute gastrostomy placement in patients with head and neck squamous cell carcinoma undergoing definitive radiation.

Lango MN, Galloway TJ, Mehra R, Ebersole B, Liu JC, Moran K, Ridge JA.

Head Neck. 2016 Apr;38 Suppl 1:E1318-24. doi: 10.1002/hed.24220. Epub 2015 Aug 31.

PMID:
26332292
31.

Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck.

Beck TN, Kaczmar J, Handorf E, Nikonova A, Dubyk C, Peri S, Lango M, Ridge JA, Serebriiskii IG, Burtness B, Golemis EA, Mehra R.

Oncotarget. 2015 Aug 7;6(22):18863-74.

32.

Head and Neck Cancers, Version 1.2015.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M.

J Natl Compr Canc Netw. 2015 Jul;13(7):847-55; quiz 856.

33.

Practice arrangement and medicare physician payment in otolaryngology.

Cracchiolo J, Ridge JA, Egleston B, Lango M.

Otolaryngol Head Neck Surg. 2015 Jun;152(6):979-87. doi: 10.1177/0194599815578102.

PMID:
26034098
34.

Why "head and neck cancer"?

Ridge JA.

Surg Oncol Clin N Am. 2015 Jul;24(3):xv-xvi. doi: 10.1016/j.soc.2015.04.001. No abstract available.

PMID:
25979405
35.

Reply to B. O'Sullivan et Al.

Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar AK, Garden AS, Soulieres D, Trotti A, Avizonis VN, Ridge JA, Harris J, Le QT, Gillison M.

J Clin Oncol. 2015 May 20;33(15):1708-9. doi: 10.1200/JCO.2014.60.3555. Epub 2015 Mar 30. No abstract available.

PMID:
25823732
36.

Bilateral granulosa cell tumors: a novel malignant manifestation of multiple endocrine neoplasia 1 syndrome found in a patient with a rare menin in-frame deletion.

Hall MJ, Innocent J, Rybak C, Veloski C, Scott WJ, Wu H, Ridge JA, Hoffman JP, Borghaei H, Turaka A, Daly MB.

Appl Clin Genet. 2015 Feb 17;8:69-73. doi: 10.2147/TACG.S72223. eCollection 2015.

37.

Current status of clinical trials in head and neck cancer 2014.

Liu JC, Ridge JA, Brizel DM, O'Sullivan B, Cohen EW, Mann BS, Adelstein DJ.

Otolaryngol Head Neck Surg. 2015 Mar;152(3):410-7. doi: 10.1177/0194599814566595. Epub 2015 Jan 20. Review.

PMID:
25605695
38.

Thyroid carcinoma, version 2.2014.

Tuttle RM, Haddad RI, Ball DW, Byrd D, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, Lydiatt WM, McCaffrey J, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ, Hoffmann KG, Hughes M.

J Natl Compr Canc Netw. 2014 Dec;12(12):1671-80; quiz 1680.

PMID:
25505208
39.

Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.

Murphy CT, Galloway TJ, Handorf EA, Wang L, Mehra R, Flieder DB, Ridge JA.

Cancer. 2015 Apr 15;121(8):1204-13. doi: 10.1002/cncr.29191. Epub 2014 Dec 9.

40.

Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Oct;12(10):1454-87.

41.

Asymptomatic Deep Peroneal Vein Thrombosis During Free Fibula Flap Harvest: A Review of the Literature, Strategies for Preoperative Assessment, and an Algorithm for Reconstruction.

Patel SA, Abdollahi H, Ridge JA, Chang EI, Lango MN, Topham NS.

Ann Plast Surg. 2016 Apr;76(4):468-71. doi: 10.1097/SAP.0000000000000355. Review.

PMID:
25275472
42.

Coupling of prostate and thyroid cancer diagnoses in the United States.

Tomaszewski JJ, Uzzo RG, Egleston B, Corcoran AT, Mehrazin R, Geynisman DM, Ridge JA, Veloski C, Kocher N, Smaldone MC, Kutikov A.

Ann Surg Oncol. 2015 Mar;22(3):1043-9. doi: 10.1245/s10434-014-4066-y. Epub 2014 Sep 10.

43.

Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512).

Trotti A 3rd, Zhang Q, Bentzen SM, Emami B, Hammond ME, Jones CU, Morrison WH, Sagar SM, Ridge JA, Fu KK, Ang KK.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):958-963. doi: 10.1016/j.ijrobp.2014.04.041. Epub 2014 Jul 8.

44.

Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials.

Chera BS, Eisbruch A, Murphy BA, Ridge JA, Gavin P, Reeve BB, Bruner DW, Movsas B.

J Natl Cancer Inst. 2014 Jul 8;106(7). pii: dju127. doi: 10.1093/jnci/dju127. Print 2014 Jul. Review.

45.

Surgery in the HPV era: the role of robotics and microsurgical techniques.

Ridge JA.

Am Soc Clin Oncol Educ Book. 2014:154-9. doi: 10.14694/EdBook_AM.2014.34.154. Review.

46.

ACR Appropriateness Criteria® thyroid carcinoma.

Salama JK, Golden DW, Yom SS, Garg MK, Lawson J, McDonald MW, Quon H, Ridge JA, Saba N, Smith RV, Worden F, Yeung AR, Beitler JJ.

Oral Oncol. 2014 Jun;50(6):577-86. doi: 10.1016/j.oraloncology.2013.12.004.

PMID:
24824115
47.

Metastatic cervical carcinoma from an unknown primary: literature review.

Arrangoiz R, Galloway TJ, Papavasiliou P, Ridge JA, Lango MN.

Ear Nose Throat J. 2014 Apr-May;93(4-5):E1-10. Review.

PMID:
24817234
48.

Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer.

Lango MN, Egleston B, Fang C, Burtness B, Galloway T, Liu J, Mehra R, Ebersole B, Moran K, Ridge JA.

Cancer. 2014 Mar 15;120(6):840-7. doi: 10.1002/cncr.28482. Epub 2013 Dec 18.

49.

Head and neck sarcomas: a comprehensive cancer center experience.

Tejani MA, Galloway TJ, Lango M, Ridge JA, von Mehren M.

Cancers (Basel). 2013 Jul 15;5(3):890-900. doi: 10.3390/cancers5030890.

50.

p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary.

Keller LM, Galloway TJ, Holdbrook T, Ruth K, Yang D, Dubyk C, Flieder D, Lango MN, Mehra R, Burtness B, Ridge JA.

Head Neck. 2014 Dec;36(12):1677-84. doi: 10.1002/hed.23514. Epub 2014 Jan 13.

Supplemental Content

Loading ...
Support Center